Literature DB >> 3980464

The use of the biotinyl estradiol-avidin system for the purification of "nontransformed" estrogen receptor by biohormonal affinity chromatography.

G Redeuilh, C Secco, E E Baulieu.   

Abstract

Several biotinyl estradiol derivatives have been prepared by coupling estradiol 7 alpha-carboxylic acid to biotin via different linear linkers. All these compounds exhibit a high affinity for the estrogen receptor as determined by competitive binding assays against [3H]estradiol. These compounds also displaced the dye 4-hydroxyazobenzene-2'-carboxylic acid from the biotin-binding sites of avidin free or immobilized on agarose. It was demonstrated that only the derivatives bearing a long spacer chain (greater than 42 A greater than) between estradiol and biotin were able to bind receptor and avidin simultaneously, suggesting some steric hindrance. The biotin-avidin system has been investigated for the purification of the cytosoluble "nontransformed" estrogen receptor stabilized by sodium molybdate. The method relies on: 1) high biohormonal affinity of receptor for biotinyl estradiol derivative; 2) the specific selection by avidin-agarose column of biotinyl estradiol-receptor complexes; and 3) the biohormonal elution step by an excess of radioactive estradiol. Starting from unfractionated cytosol containing molybdate-stabilized nontransformed 8S estrogen receptor with estradiol 7 alpha-(CH2)10-CO-NH-(CH2)2-O-(CH2)2-O-(CH2)2-NH-CO-(CH2)3-NH-biotin, preliminary experiments using avidin-agarose chromatography and then a specific elution step by exchange with free [3H]estradiol, allowed a 500-1,500-fold purification. Further purification of estrogen receptor was obtained by ion exchange chromatography through a DEAE-Sephacel column and led to a congruent to 20% pure protein, assuming one binding site/65,000-Da unit. The hydrodynamic parameters of the purified receptor were essentially identical to those of molybdate-stabilized nontransformed receptor present in crude cytosol. The advantages of this double biotinyl steroid derivative-avidin chromatographic technique over more conventional affinity procedures are discussed and make it applicable to the purification of minute amounts of steroid receptors in a wide variety of tissues.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3980464

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  [Biocytin13]dynorphin A 1-13 amide: a potential probe for the kappa-opioid receptor.

Authors:  G Hochhaus; A Patthy; R Schwietert; D V Santi; W Sadée
Journal:  Pharm Res       Date:  1988-12       Impact factor: 4.200

2.  Chemical synthesis and biochemical characterization of a biotinylated derivative of 17beta-estradiol with a long side chain covalently attached to its C-7alpha position.

Authors:  Xiang-Rong Jiang; Pan Wang; Xinmiao Fu; Bao Ting Zhu
Journal:  Steroids       Date:  2008-06-22       Impact factor: 2.668

3.  New probes for angiotensin II receptors. Synthesis, radioiodination and biological properties of biotinylated and haptenated angiotensin derivatives.

Authors:  J C Bonnafous; M Tence; R Seyer; J Marie; A Aumelas; S Jard
Journal:  Biochem J       Date:  1988-05-01       Impact factor: 3.857

4.  Bisphenol A directly targets tubulin to disrupt spindle organization in embryonic and somatic cells.

Authors:  Olivia George; Bj K Bryant; Ramesh Chinnasamy; Cesear Corona; Jeffrey B Arterburn; Charles B Shuster
Journal:  ACS Chem Biol       Date:  2008-01-29       Impact factor: 5.100

5.  Probing adenosine nucleotide-binding proteins with an affinity-labeled nucleotide probe and mass spectrometry.

Authors:  Haibo Qiu; Yinsheng Wang
Journal:  Anal Chem       Date:  2007-06-30       Impact factor: 6.986

6.  Synthesis and application of a photoaffinity analog of dehydroepiandrosterone (DHEA).

Authors:  Horacio F Olivo; Nury Perez-Hernandez; Dongmin Liu; Mary Iruthayanathan; Brianne O'Leary; Laurie L Homan; Joseph S Dillon
Journal:  Bioorg Med Chem Lett       Date:  2009-12-06       Impact factor: 2.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.